Inactive Instrument

Press Releases BioSpecifics Technologies Corp.

Equities

BSTC

US0909311062

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

BIOSPECIFICS TECHNOLOGIES CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	20-12-02	AQ
BioSpecifics Technologies : Endo Announces Expiration of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer	20-11-19	AQ
BioSpecifics Technologies : Endo Announces Expiration Of Hart-Scott-Rodino Waiting Period For BioSpecifics Tender Offer	20-11-18	AQ
BioSpecifics Technologies : Reports Third Quarter 2020 Financial and Operating Results	20-11-10	AQ
BIOSPECIFICS TECHNOLOGIES : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	20-11-09	AQ
BioSpecifics: 3Q Earnings Snapshot	20-11-09	AQ
BioSpecifics Technologies : Reports Third Quarter 2020 Financial and Operating Results	20-11-09	PR
BioSpecifics Technologies : Endo Reports Third-Quarter 2020 Financial Results and Raises Full Year 2020 Financial Guidance	20-11-06	AQ
BIOSPECIFICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioSpecifics Technologies Corp. - BSTC	20-11-03	BU
BioSpecifics Technologies : Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.	20-11-03	AQ
BioSpecifics Technologies : Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.	20-11-02	AQ
BIOSPECIFICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioSpecifics Technologies Corp. - BSTC	20-10-26	BU
BioSpecifics Technologies : to be acquired by Endo Pharmaceuticals	20-10-20	AQ
BioSpecifics Technologies : Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX and Qwo	20-10-20	AQ
BIOSPECIFICS TECHNOLOGIES CORP : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	20-10-19	AQ
BioSpecifics Technologies : Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™	20-10-19	AQ
BioSpecifics Technologies : to Present at the Virtual Oppenheimer and Co. Fall Healthcare Life Sciences and MedTech Summit	20-09-15	AQ
BIOSPECIFICS TECHNOLOGIES CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-09-14	AQ
BioSpecifics Technologies : to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit	20-09-14	PR
BioSpecifics Technologies : to Present at the H.C. Wainwright Virtual Healthcare Conference	20-09-08	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioSpecifics Technologies Corp.

Equities

BSTC

US0909311062

Press Releases

Filters